Omalizumab for treatment of chronic urticaria: A review of effective dose
Omalizumab or Xolair®, a humanized anti-IgE monoclonal antibody, is effective and well-tolerated in patients with chronic spontaneous urticaria refractory to H1 antihistamines. The web search of several databases, including PubMed, EMBASE, Scopus, Google, SID, Magiran, and Irandoc, led to the select...
Salvato in:
Autori principali: | , |
---|---|
Natura: | Libro |
Pubblicazione: |
Mazandaran University of Medical Sciences,
2019-03-01T00:00:00Z.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Accesso online
Connect to this object online.3rd Floor Main Library
Collocazione: |
A1234.567 |
---|---|
Copia 1 | Disponibile |